Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dermal filler tested for wrinkle reduction

NCT ID NCT07329608

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at the safety and performance of RefillHA Volume, a dermal filler used to smooth facial wrinkles and add volume. It involved 78 adults who wanted wrinkle correction. Researchers tracked side effects and how well the filler worked in everyday clinic use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RefillHA Volume (hyaluronic acid dermal filler)
What this could lead to
If results are positive, it could confirm that RefillHA Volume is a safe and effective option for reducing facial wrinkles and folds.
What could go wrong
This is a small, completed observational study with no comparison group, so results may not apply to everyone. Side effects like swelling or bruising are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

78 people

The number who actually took part.

Started

Jan 2024

Finished

May 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects over the age of 18 who are seeking correction of facial wrinkles and folds and/or soft tissue augmentation.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult men and women, over the age of 18, seeking correction of facial wrinkles and folds and/or soft tissue augmentation. * Subjects who are willing and able to read, understand and sign informed consent. Exclusion Criteria: * Subjects with known contraindications to the treatment (as per device IFU). * Subjects considered to be unsuitable to participate, in the investigator's opinion, for any reason.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wrinkles are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Glyance Ltd

    Lod, 7152026, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.